Available Until 5/20/2025

Vaccine Preventable Diseases: Tetanus

ACPE Activity Number: 0204-0000-23-086-H06-P
Release Date: 05/20/2023
Expiration Date: 05/20/2025 
Activity Type: Knowledge-based
CE Credits:  0.5 contact hour, no partial credit
Activity Fee: Member – Free / Non-Member – Not Available 

Activity Overview 

Tetanus is becoming rarer in both industrialized and developing nations due to an effective vaccination program. It is difficult to conduct trials on different treatment modalities in tetanus due to both logistical and ethical reasons. However, it is imperative that physicians are aware of the best evidence-based treatment strategies currently available to improve the outcome of patients. 

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.

These activities were planned to meet the educational needs of pharmacists who encounter an unvaccinated patient who presents with signs and symptoms of tetanus. 

After completing this activity, the learner should be able to…

  • Describe the signs and symptoms of tetanus.
  • Identify appropriate treatment options for the management of tetanus. 

  • Introduction and Announcements 

  • Presentation  

Norm Fenn, PharmD, BCPS, BCPPS
Manchester University College of Pharmacy, Natural, and Health Sciences
Pediatric Clinical Pharmacist
Parkview Women’s & Children’s Hospital
Fort Wayne, IN  

Vicki Basalyga, PharmD, MAS, BCPS, BCPPS
Director, Member Relations

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

  • No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company. 

Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.